BOSTON, April 11, 2024 /PRNewswire/ --
The Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, has announced the "
10th International TFOS Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance" to be held from
October 30th through November 2, 2024 at the Hilton Molino Stucky in
Venice,
Italy.
Conference objectives are two-fold. First, to assess the current knowledge and 'state of the art' research on the structure and function of tear film producing tissues, tears, and the ocular surface in both health and disease. Second, to promote an international exchange of information that will be of value to basic scientists involved in eye research, to clinicians in the eye care community, and to companies with an interest in the diagnosis and treatment of tear film and/or ocular surface disorders.
"This is the first in-person TFOS international conference since 2016! Although typically held every 4 years, the last TFOS Conference had to be canceled because of the global pandemic. We look forward to bringing everyone together once again," noted
David A. Sullivan, PhD, Founder, TFOS.
Platform Sessions:
Conference Address ("The future of tear film and ocular surface research")
Ocular surface disease: What we do to ourselves
East, West, North, South: Impact of geographic region and ethnicity on the prevalence and management of ocular surface disease
New insights into the pathophysiology and management of catastrophic ocular surface diseases
Seeing differently: The meaning of blindness
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment
TFOS i2 Innovation Showcase
Meibomian gland dysfunction update
TFOS Dry Eye Workshop III (TFOS DEWS III)
Models and biomarkers for ocular surface disease
Did you know?
Limbal stem cell deficiency
Eye surgery, intravitreal injections and iatrogenic ocular surface disease
What a nerve!
The microbiome: Do we need to keep an eye on it?
Poster Presentations:
Abstract submission is open. All abstracts must be submitted no later than August 2, 2024. TFOS will inform first authors if their abstract was accepted within two weeks after abstract submission. All accepted abstracts, except those from invited speakers, will be assigned as poster presentations.
Registration for the TFOS Conference is available on:
"As we see the prevalence of dry eye continuing to increase, the TFOS Conference plays a critical role in convening top experts and highlighting the latest advancements in ocular surface disease treatments. We share TFOS' commitment to address the needs of patient's suffering from dry eye and other ocular surface conditions, which is why we look forward to being the title sponsor at the 10th International TFOS Conference," said
Yehia Hashad, M.D.,
executive vice president, Research and Development and chief medical officer, Bausch + Lomb.
Sponsors
TFOS Conference sponsors include Bausch + Lomb (Title Sponsor), Dompé, Bruder, Espansione Group, Brill International, SINQI, Hangzhou Mocular, SIFI, Essiri Labs, Laboratorios Sophia, Théa, Intalight, and Santen Pharmaceutical.
ABOUT TFOS
Founded in 2000, the Tear Film & Ocular Surface Society is a world leader in eye health education headquartered in Boston, USA. A 501(c)3 non-profit foundation, TFOS is dedicated to advancing the research, literacy, and educational aspects of the scientific field of the eye's surface. More information about TFOS is available at: tearfilm.org
Contact:
Amy Gallant Sullivan
Executive Director
[email protected]
SOURCE TFOS - Tear Film & Ocular Surface Society